Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Steve Cohen Bought Medical Device Stock ArthroCare

Page 1 of 2

SAC CAPITAL ADVISORSSAC Capital Advisors isn’t going to let the current speculation and investigation into insider trading by past employees of the fund interfere with its investing activities. A recent 13G filed with the SEC shows that the fund, which is managed by billionaire Steven Cohen, owns 1.6 million shares of medical device company ArthroCare Corporation (NASDAQ:ARTC). This gives it 5.6% of the shares outstanding. ArthroCare is best known for products which help treat orthopedic and soft tissue conditions. SAC had owned about 400,000 shares of the company at the beginning of October, and that had been an increase of 250% from the size of its position at the end of June (check out more of Cohen’s stock picks and read our latest report on the insider trading probe). As such this seems to have been a fairly recent buy by Cohen and his team, and with the stock about flat since the end of September investors have the opportunity to buy in at a similar price.

ArthroCare Corporation has a market capitalization of a little over $900 million; it averages about 140,000 shares traded daily, and has a current market price of about $33 per share, giving it close to $5 million in average daily dollar volume. The company’s most recent 10-Q showed a small increase in product sales compared to the third quarter of 2011. Because ArthroCare did not report as much in exit, investigation, and restatement costs, earnings were up substantially from a year ago. However, for the fuller year, income seems to be more steady and it looks to us like the company merely had a number of one-time charges in Q3 2011- there hasn’t been much actual growth. A little over two-thirds of the company’s business comes from the United States. At the current stock price, ArthroCare trades at 22 times forward earnings estimates. This is a valuation at which we’d expect to see substantial growth in the company’s business.

Healthcor Management, a healthcare-focused hedge fund managed by two former SAC employees (Arthur Cohen and Joseph Healey), reported owning nearly 2 million shares of ArthroCare Corporation at the end of September, making the stock one of the fund’s ten largest holdings by market value (see what other healthcare stocks they thought were good investments). Healthcor had been increasing its stake in the company earlier this year. Renaissance Technologies, whose founder Jim Simons is now a multi-billionaire thanks to the fund’s success, had reported owning about 400,000 shares though this had been a 15% decrease from three months earlier (find more stocks that Renaissance was trading).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!